SCHEMBL453425

SCHEMBL453425

CN(C)C(C)(C)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL27747712 0.97 TSHR (0.42)
Hydrochloric Acid SCHEMBL3302683 0.97 TSHR (0.42)
Water SCHEMBL29273169 0.97 TSHR (0.42)
Acetic Acid Methyl Ester SCHEMBL27597825 0.84 ALDH1A1 (0.48)
Propylene Glycol SCHEMBL1497509 0.81 TDP1 (0.43)
SCHEMBL22692560 0.80 TSHR (0.44)
SCHEMBL8161352 0.76 TSHR (0.47)
SCHEMBL166937 0.75
SCHEMBL20954056 0.75
SCHEMBL27768532 0.75 TSHR (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 506 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12139755-B2 Methods of RNA amplification ASURAGEN, INC. (US) 2024-11-12 US claimed
US-20240293300-A1 SKIN PENETRATION COSMETIC MATERIAL, AND SKIN PENETRATION COSMETIC MATERIAL PRODUCTION METHOD SHISEIDO COMPANY, LTD. (JP) 2024-09-05 US claimed
CN-117098854-A Hybridization buffer formulations 豪夫迈·罗氏有限公司 2023-11-21 CN claimed
CN-116660543-A Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof 中国人民解放军陆军军医大学第一附属医院 2023-08-29 CN claimed
WO-2023002873-A1 SKIN PENETRATION COSMETIC MATERIAL, AND SKIN PENETRATION COSMETIC MATERIAL PRODUCTION METHOD 株式会社資生堂 2023-01-26 WO claimed
US-20220177949-A1 METHODS OF RNA AMPLIFICATION ASURAGEN, INC. 2022-06-09 US claimed
US-11236384-B2 Methods of RNA amplification ASURAGEN, INC. (US) 2022-02-01 US claimed
CN-111265467-A An anti-allergy repairing agent prepared by mixing stem cell extract and compound plant extract, and its preparation method 上海梅格医疗器械有限公司 2020-06-12 CN claimed
US-20170182108-A1 FERMENTED FOOD EXTRACT COMPOSITION SHINSHU UNIVERSITY (JP) 2017-06-29 US claimed
CN-106176291-A Hand-mouth baby wet tissue compositional liquor and wet tissue 金红叶纸业集团有限公司 2016-12-07 CN claimed
EP-1933642-A1 SALT ENHANCING COMPOUNDS AND USE Thomas Frank Hofmann & Andreas Dunkel Inst. für Lebensmittelchemie (DE) 2008-06-25 EP claimed
WO-2007042274-A1 SALT ENHANCING COMPOUNDS AND USE THOMAS FRANK HOFMANN & ANDREAS DUNKEL (DE) 2007-04-19 WO claimed
US-20050217537-A1 Formulations and methods for rendering materials flame retardant and resistant to molds and insects KNIPE ERIC V 2005-10-06 US claimed
WO-2005087462-A1 FORMULATIONS AND METHODS FOR RENDERING MATERIALS FLAME RETARDANT AND RESISTANT TO MOLDS AND INSECTS BETANIX COATINGS, INC. (US) 2005-09-22 WO claimed
US-20040121025-A1 Oral composition for the treatment and prevention of bone loss PRO-HEALTH, INC. 2004-06-24 US claimed
EP-0950046-B1 3,4-DISUBSTITUTED AZETIDIN-2-ONE DERIVATIVES USEFUL AS CYSTEINE PROTEINASE REGULATORS NAEJA PHARMACEUTICAL INC (CA) 2002-04-10 EP claimed
EP-0961779-A1 SUBSTITUTED AMINO BICYCLIC-$g(b)-LACTAM PENAM AND CEPHAM DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS SYNPHAR LABORATORIES INC. (CA) 1999-12-08 EP claimed
EP-0950046-A1 3,4-DISUBSTITUTED AZETIDIN-2-ONE DERIVATIVES USEFUL AS CYSTEINE PROTEINASE REGULATORS SYNPHAR LABORATORIES INC. (CA) 1999-10-20 EP claimed
WO-1998032766-A1 SUBSTITUTED AMINO BICYCLIC-β-LACTAM PENAM AND CEPHAM DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS SYNPHAR LABORATORIES INC. (US) 1998-07-30 WO claimed
WO-1998012176-A1 3,4-DISUBSTITUTED AZETIDIN-2-ONE DERIVATIVES USEFUL AS CYSTEINE PROTEINASE REGULATORS SYNPHAR LABORATORIES INC. (US) 1998-03-26 WO claimed